Professionals 213 Users Online

Biosimulation Market

Global Market Study on Biosimulation: North America to Dominate the Market in Terms of Revenue During the Forecast Period (2017 - 2022)

Biosimulation Market Segmented By Software, Services Product in Drug Development, Drug Discovery


Biosimulation is a technique in which computer programs are used for the simulation of biological processes. Biosimulation has wide reaching applications in the field of drug discovery and development of new drugs. It is a tool used for prediction and biosimulation is used to predict the future outcomes of current experiments related to discovery and development of new drugs.

The process of drug discovery and development is a costly one, and the failure of the drug molecule in the late phase of drug development translates into a huge wastage of time, money and other resources. Hence, there is a need of a predictive tool that will aid in predicting the future outcomes of drug development by simulation of the biological processes involved.

This is the most important factor driving the global biosimulation market. The other factors supporting the growth of the biosimulation market are the increasing expenditure on healthcare, development of advanced software and improved technology related to simulation.

According to the assessment of Persistence Market Research, the global biosimulation market is forecasted to reach a figure of about US$ 1,750 Mn in 2022 and is poised to exhibit a robust CAGR in the period of assessment.

Global Biosimulation Market

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

North America Market Set to Dominate the Global Biosimulation Market in Terms of Revenue

The market in North America is set to dominate the global biosimulation market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America biosimulation market is the most attractive market, growing at a robust CAGR over the forecast period.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Software Product Type Segment Slated to Touch a Value of About US$ 1,050 Mn in 2022

According to the projections of Persistence Market Research, the software product type segment is expected to reach a value of about US$ 1,050 Mn in the year 2022. This signifies a robust CAGR during the forecast period of 2017-2022.

The software product type segment is estimated to account for nearly two-thirds of the revenue share of the product segment by the end of the year 2017 and is expected to lose in market share by 2022 over 2017.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global biosimulation market through 2022, which include Certara, L.P., Simulations Plus, Inc., Dassault Systemes SE, Schrodinger, Inc., Advanced Chemistry Development, Inc., Entelos, Inc., Evidera, Inc., Genedata AG, Leadscope Inc. and Acceryls Inc.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Persistence Market Research

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Market Taxonomy

Attribute Details


  • Software
  • Services

End User

  • Academic and Government Research Institutes
  • Pharmaceutical and Biotech Companies
  • Contract Research Organizations
  • Regulatory Authorities
  • Other End Users


  • Drug Development
  • Drug Discovery
  • Other Applications


  • North America
  • Latin America
  • Europe
  • Japan
  • Asia Pacific excluding Japan
  • Middle East and Africa

- Companies Covered in This Report -

  • Certara, L.P
  • Simulations Plus, Inc..
  • Dassault Systemes SE
  • Schrodinger, Inc
  • Advanced Chemistry Development, Inc.
  • Entelos, Inc.
  • Evidera, Inc.
  • Genedata AG
  • Leadscope Inc
  • Acceryls Inc.
  • Others.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate